Adherence to Topical Hydrocortisone 17-Butyrate 0.1% in Different Vehicles in Adults with Atopic Dermatitis

December 2008 in “ Journal of The American Academy of Dermatology ”

Rebekah L. Wilson, Fabian Camacho, Adele Clark, Trudye A. Young, Robin Inabinet, Brad A. Yentzer, Steven R. Feldman

New to Hydrocortisone? There is a guide in the encyclopedia. Read the guide →

hydrocortisone 17-butyrate topical corticosteroids atopic dermatitis Investigators Global Assessment cream lipocream ointment hydrocortisone topical steroids eczema IGA

Studysummary This study found that adherence to topical hydrocortisone in adults with atopic dermatitis was inconsistent and not significantly different across different medication vehicles, though disease severity improved markedly within 2 weeks.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer ·

View this study on jaad.org →

Discuss this study in the Community →

Similar Research

5 / 1000+ results

Study on Toxicity of Hydrocortisone 17-Butyrate 21-Propionate: Subacute Toxicity in Dogs by Percutaneous Administration

research STUDIED ON TOXICITY OF HYDROCORTISONE 17-BUTYRATE 21-PROPIONATE : 6. Subacute Toxicity in Dogs by Percutaneous Adminisration

January 1981 in “The Journal of Toxicological Sciences”

In this study, beagle dogs treated with hydrocortisone 17-butyrate 21-propionate ointment showed various toxic effects, including acne-like skin changes and organ atrophy, which returned to normal after a recovery period.

research A consideration when interpreting outpatient data

May 2011 in “Journal of The American Academy of Dermatology”

This research letter observed that patients with severe atopic dermatitis showed normal serum cortisol levels after hospitalization despite continued use of potent topical corticosteroids, though poor adherence may lead to overestimations of actual medication use.

Treatment of Alopecia Areata with Topical Corticosteroid: Prospective Double-Blind Randomized Study in Children

research Tratamento da alopecia areata com corticóide tópico: estudo prospectivo randomizado duplo cego em crianças * Therapy of alopecia areata with topical corticosteroid: prospective double-blind controlled assay in children *

January 2003

In this study, no significant difference was found between the efficacy of betamethasone dipropionate cream and placebo in treating alopecia areata in children, regardless of atopic status.

research Clobetasol Propionate, 0.05%, vs Hydrocortisone, 1%, for Alopecia Areata in Children

49 citations , November 2013 in “JAMA dermatology”

This study found that topical clobetasol propionate cream was more effective than hydrocortisone cream in reducing hair loss surface area in children with patchy alopecia areata over 24 weeks, with no serious adverse effects.

research Topical corticosteroid in foam vehicle offers comparable coverage compared with traditional vehicles

7 citations , June 2000 in “Journal of the American Academy of Dermatology”

This study found that betamethasone valerate in a foam vehicle has comparable total coverage to traditional topical corticosteroid vehicles, despite less coverage per unit of foam.